ES2806150T3 - Sales alcaloides de cincona bis-cuaternaria como catalizadores de transferencia de fases asimétricos - Google Patents

Sales alcaloides de cincona bis-cuaternaria como catalizadores de transferencia de fases asimétricos Download PDF

Info

Publication number
ES2806150T3
ES2806150T3 ES13761100T ES13761100T ES2806150T3 ES 2806150 T3 ES2806150 T3 ES 2806150T3 ES 13761100 T ES13761100 T ES 13761100T ES 13761100 T ES13761100 T ES 13761100T ES 2806150 T3 ES2806150 T3 ES 2806150T3
Authority
ES
Spain
Prior art keywords
alkyl
bis
quaternary
halogen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13761100T
Other languages
English (en)
Spanish (es)
Inventor
Bangping Xiang
Nobuyoshi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp & Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp & Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp & Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2806150T3 publication Critical patent/ES2806150T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0277—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature
    • B01J31/0278—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre
    • B01J31/0285—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides comprising ionic liquids, as components in catalyst systems or catalysts per se, the ionic liquid compounds being used in the molten state at the respective reaction temperature containing nitrogen as cationic centre also containing elements or functional groups covered by B01J31/0201 - B01J31/0274
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201—Oxygen-containing compounds
    • B01J31/0204—Ethers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235—Nitrogen containing compounds
    • B01J31/0239—Quaternary ammonium compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235—Nitrogen containing compounds
    • B01J31/0244—Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0271—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds also containing elements or functional groups covered by B01J31/0201 - B01J31/0231
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42—Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • B01J2231/4272—C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type via enolates or aza-analogues, added as such or made in-situ, e.g. ArY + R2C=C(OM)Z -> ArR2C-C(O)Z, in which R is H or alkyl, M is Na, K or SiMe3, Y is the leaving group, Z is Ar or OR' and R' is alkyl
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/90—Catalytic systems characterized by the solvent or solvent system used
    • B01J2531/98—Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases
    • B01J2531/985—Phase-transfer catalysis in a mixed solvent system containing at least 2 immiscible solvents or solvent phases in a water / organic solvent system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES13761100T 2012-03-14 2013-03-13 Sales alcaloides de cincona bis-cuaternaria como catalizadores de transferencia de fases asimétricos Active ES2806150T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610746P 2012-03-14 2012-03-14
PCT/US2013/030688 WO2013138413A1 (en) 2012-03-14 2013-03-13 Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts

Publications (1)

Publication Number Publication Date
ES2806150T3 true ES2806150T3 (es) 2021-02-16

Family

ID=49161748

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13761100T Active ES2806150T3 (es) 2012-03-14 2013-03-13 Sales alcaloides de cincona bis-cuaternaria como catalizadores de transferencia de fases asimétricos

Country Status (12)

Country Link
US (1) US9376431B2 (enExample)
EP (4) EP4019516A1 (enExample)
JP (1) JP6140266B2 (enExample)
KR (2) KR102061180B1 (enExample)
CN (1) CN104144929B (enExample)
AU (6) AU2013232191B2 (enExample)
BR (1) BR112014021828B8 (enExample)
CA (1) CA2865941A1 (enExample)
ES (1) ES2806150T3 (enExample)
MX (1) MX351657B (enExample)
RU (1) RU2667909C2 (enExample)
WO (1) WO2013138413A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI501968B (zh) * 2010-11-12 2015-10-01 Merck Sharp & Dohme 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑
WO2013138418A2 (en) 2012-03-14 2013-09-19 Merck Sharp & Dohme Corp. Process for making cgrp receptor antagonists
US9174989B2 (en) 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists
US12168004B2 (en) 2014-02-05 2024-12-17 Merck Sharp & Dohme Llc Treatment of migraine
US10117836B2 (en) 2014-02-05 2018-11-06 Merck Sharp & Dohme Corp. Tablet formulation for CGRP active compounds
RU2731944C2 (ru) 2016-06-07 2020-09-09 Пирелли Тайр С.П.А. Шина для колес транспортных средств
CA3065683A1 (en) 2017-05-30 2018-12-06 Millennium Pharmaceuticals, Inc. Method for producing optically active compound
US12383545B1 (en) 2018-06-08 2025-08-12 Allergan Pharmaceuticals International Limited Treatment of migraine
CN109180606B (zh) * 2018-09-30 2021-04-06 浙江工业大学 一类具有光学活性的β-氨基酮的合成方法
MX2022013872A (es) * 2020-05-06 2022-11-30 Amgen Inc Sintesis de productos intermedios de alcohol vinilico.
MX2023001071A (es) 2020-07-29 2023-05-12 Allergan Pharmaceuticals Int Ltd Tratamiento de la migraña.
CN116490507A (zh) 2020-09-10 2023-07-25 薛定谔公司 用于治疗癌症的杂环包缩合cdc7激酶抑制剂
CA3206184A1 (en) 2020-12-22 2022-06-30 Allergan Pharmaceuticals International Limited Treatment of migraine
JP2024533756A (ja) 2021-09-27 2024-09-12 アラガン ファーマスーティカルズ インターナショナル リミテッド アトゲパントを含む片頭痛の併用療法
CN115974867B (zh) * 2023-01-31 2025-11-28 成都大学 一种手性相转移催化剂及其制备方法和应用
CN117603205A (zh) * 2023-12-20 2024-02-27 杭州澳赛诺生物科技有限公司 一种奎尼丁衍生物手性相转移催化剂的合成方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0438796T3 (da) 1990-01-22 1999-05-25 Hoechst Marion Roussel Inc Fremgangsmåde til enantioselektiv syntese af alkylerede oxindoler, som anvendes som mellemprodukter ved fremstilling af phy
DE69727679T2 (de) 1996-06-05 2004-07-22 Lindner, Wolfgang, Prof. Dr. Auf cinchonan basierte chirale selektoren zur trennung von stereoisomeren
US6596870B2 (en) 2000-07-13 2003-07-22 Brandeis University Asymmetric synthetic methods based on phase transfer catalysis
ATE520661T1 (de) * 2003-06-27 2011-09-15 Univ Maryland Heterocyclische verbindungen mit quaternärem stickstoff zum nachweis von wässrigen monosacchariden in physiologischen flüssigkeiten
GB0601286D0 (en) * 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
PL213306B1 (pl) * 2008-02-04 2013-02-28 Politechnika Lodzka Sposób otrzymywania wzbogaconych enancjomerycznie produktów kondensacji z kwasów racemicznych lub kwasów o niskiej czystosci enancjomerycznej
WO2011005731A2 (en) * 2009-07-08 2011-01-13 Merck Sharp & Dohme Corp. Process for making cgrp receptor antagonist
WO2013138418A2 (en) 2012-03-14 2013-09-19 Merck Sharp & Dohme Corp. Process for making cgrp receptor antagonists
US9174989B2 (en) 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists

Also Published As

Publication number Publication date
JP6140266B2 (ja) 2017-05-31
US20150031891A1 (en) 2015-01-29
KR20200003243A (ko) 2020-01-08
AU2017204464A1 (en) 2017-07-20
AU2017204464B2 (en) 2019-04-18
BR112014021828B1 (pt) 2019-04-24
KR20140138704A (ko) 2014-12-04
CA2865941A1 (en) 2013-09-19
AU2023254886A1 (en) 2023-11-16
CN104144929B (zh) 2016-09-14
AU2013232191A1 (en) 2014-08-21
AU2025220879A1 (en) 2025-09-11
CN104144929A (zh) 2014-11-12
EP2825536A4 (en) 2015-10-28
WO2013138413A1 (en) 2013-09-19
JP2015516945A (ja) 2015-06-18
EP2825536B1 (en) 2020-06-17
AU2013232191B2 (en) 2017-03-30
BR112014021828B8 (pt) 2023-04-18
MX351657B (es) 2017-10-23
US9376431B2 (en) 2016-06-28
AU2019206049B2 (en) 2021-04-01
EP4357020A3 (en) 2024-06-26
AU2019206049A1 (en) 2019-08-01
MX2014010999A (es) 2014-10-13
RU2014141166A (ru) 2016-05-10
KR102061180B1 (ko) 2019-12-31
EP3680240A1 (en) 2020-07-15
EP4357020A2 (en) 2024-04-24
EP4019516A1 (en) 2022-06-29
EP2825536A1 (en) 2015-01-21
KR102153850B1 (ko) 2020-09-08
AU2021204629A1 (en) 2021-07-29
RU2667909C2 (ru) 2018-09-25

Similar Documents

Publication Publication Date Title
AU2019206049B2 (en) Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts
ES2929528T3 (es) Derivados de pirazolopirimidina como inhibidores de BTK para el tratamiento del cáncer
AU2016355710B2 (en) Modulators of ROR-gamma
TWI856471B (zh) 一種DNA聚合酶theta抑制劑及其應用
EP4126860A1 (en) Monoacylglycerol lipase modulators
CA2869239A1 (en) Pyranopyridone inhibitors of tankyrase
JP2025530222A (ja) 2-置換ピペリジン誘導体、その製造方法及び医薬的用途
AU2022215237A1 (en) Methods of preparing indolinobenzodiazepine derivatives
Wang et al. The reaction of β-lactam carbenes with 3, 6-dipyridyltetrazines: switch of reaction pathways by 2-pyridyl and 4-pyridyl substituents of tetrazines
WO2014184808A1 (en) Spiro-oxazines, indolinones and preparation thereof
Danehchin et al. Efficient synthesis of novel chromenopyrido [3, 2-e] isothiazolo [2, 3-a] pyrimidines via a non-catalytic one-pot three-component reaction
Pelletier et al. A general synthesis of tetrahydropyrazolo [3, 4-d] thiazoles
Begum et al. A sustainable one-pot multi-component approach toward the synthesis of symmetric and unsymmetrical spiro heterocycles catalyzed by the Brønsted acidic ionic liquid [CMMIM][BF4]
ES2246170B1 (es) Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
WO2025153712A1 (en) Tricyclic compounds, preparation thereof and therapeutic uses as erk5 inhibitors
CA3216995A1 (en) Processes for the preparation of (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl) methyl)benzyl) amino)isoindoline-1,3-dione
AU2022284188A1 (en) 2, 8-diazaspiro [4.5] decane compounds
Singh et al. Malononitrile: A Key Reagent for the Synthesis of Medicinally Promising Fused and Spiro Pyridine Derivatives in Multicomponent Reactions